Abstract
Objective
To study growth hormone levels in IUGR and healthy controls and its association with birth weight and ponderal index.
Methods
We studied 50 Intra uterine growth retarded (IUGR) and 50 healthy newborns born at term by vaginal delivery in JIPMER, Pondicherry, India. Cord blood was collected at the time of delivery for measurement of growth hormone.
Results
When compared with healthy newborns, IUGR newborns had higher growth hormone levels (mean ± SD, 23.5 ± 15.6 vs 16.2 ± 7.61 ngm/ml, P = 0.019). A negative correlation was identified between growth hormone levels and birth weight (r2 = − 0.22, P = 0.03) and ponderal index (r2 = − 0.36, P = 0.008). Correlation of growth hormone levels was much more confident with ponderal index than with birth weight.
Conclusion
At birth IUGR infants display increased growth hormone levels which correlate with ponderal index much more confidently than with birth weight.
Similar content being viewed by others
References
Arias, F. Fetal growth retardation. In Practical guide to high-risk pregnancy and delivery, 2nd ed. St. Louis; Mosby year book Inc., 1993; 301–304.
Dunn PM. The search for perinatal definitions and standards. Acta Paediatr Scand Suppl 1985; 319: 7–16.
Stoll BJ, Kliegman RM. The high risk infant. In Berhman RE ed. Nelson Text Book of Pediatrics. 17th ed. Philadelphia; Saunders, 2004; 550–551.
Nair MKC. Early Child Development, the Kerala Model. Childhood Disability Update 2001; 1: 2–6.
Holeman K, Aerts L, Assche FAV. Lifetime consequences of abnormal fetal pancreatic development. J Physiol 2003; 547: 11–20.
Karlberg J, Albertsson-Wikland K. Growth in full-term small-for-gestational-age infants: from birth to final height. Pediatr Res 1995; 38: 733–739.
Barker DJP. Mothers, Babies and Disease in Later Life. London; BMJ Publishing, 1994: 78–94
Frankenne F, Closset J, Gomez F, Scippo ML, Smal J, Hennen G. The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant. J Clin Endocrinol Metab 1988; 66: 1171–1180.
Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev 1994; 15: 80–103.
Efstratiadis A. Genetics of mouse growth. Int J Dev Biol 1998; 42: 955–976.
Lassare C, Hardouin S, Daffos F, Forestier F, Frankenne F, Binoux M. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus: relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res 1991; 29: 219–225.
Setia S, Sridhar MG, Bhat V, Chaturvedula L, Vinayagamoorti R, John M. Insulin sensitivity and insulin secretion at birth in intrauterine growth retarded infants. Pathology 2006; 38: 236–238.
Setia S, Sridhar MG, Koner BC, Bobby Z, Bhat V, Chaturvedula L. Increased insulin sensitivity in intrauterine growth retarded newborns — Do thyroid hormones play a role? Clin Chim Acta 2007; 376: 37–40.
Ogilvy-Stuart AL, Hands SJ, Adcock CJ, Holly JMP, Matthews DR, Mohamed-Ali V et al. Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein, growth hormone and feeding in the newborn. J Clin Endocrinol Metab 1998; 83: 3550–3557.
Massa G, de Zegher F, Vanderschueren-Lodeweyckx M. Serum growth hormone-binding protein in the human fetus and infant. Pediatr Res 1992; 32: 69–72.
Handwerger S. The physiology of placental lactogen in human pregnancy. Endocr Rev 1992; 12: 329–336.
Freemark M, Handwerger S. The role of placental lactogen in the regulation of fetal metabolism. J Pediatr Gastroenterol Nutr 1989; 8: 281–287.
Grumbach MM, Gluckman PD. The human fetal hypothalamus and pituitary gland: the maturation of neuroendocrine mechanisms controlling the secretion of fetal pituitary growth hormone, prolactin, gonadotropins, adrenocorticotropin-related peptides and thyrotropin. In Tulchinsky D, Little AB, eds. Maternal and Fetal Endocrinology, 2nd ed. Philadelphia: Saunders, 1994; 193–261.
Wit JM, van Unen H. Growth of infants with neonatal growth hormone deficiency. Arch Dis Child 1992; 67: 920–924.
Parkes MJ, Bassett JM. Antagonism by growth hormone of insulin action in fetal sheep. J Endocrinol 1985; 105: 379–382.
Werther GA, Haynes KM, Barnard R, Waters MJ. Visual demonstration of growth hormone receptors on human growth plate chondrocytes. J Clin Endocrinol Metab 1990; 70: 1725–1730.
Gluckman PD, Cutfield W, Harding JE et al. Metabolic consequences of intrauterine growth retardation. Acta Paediatr 1996; 417: 3–6.
Bauer MK, Breier BH, Harding JE, Veldhuis JD, Gluckman PD. The fetal somatotropic axis during long-term maternal undernutrition in sheep: evidence for nutritional regulation in utero. Endocrinology 1995; 136: 1250–1257.
Woods KA, Camacho-Hubner C, Savage MO, Clark AJL. Intrauterine growth retardation and postnatal growth failure associated with deletion of the igf-1 gene. N Engl J Med 1996; 335: 1363–1367.
Fowelin J, Attvall S, von Schenck, Smith U, Lager I. Characterization of the insulin-antagonistic effect of growth hormone in man. Diabetologia 1991; 34: 500–506.
Adrian TE, Lucas A, Bloom SR, Aynsley-Green A. Growth hormone response to feeding in term and preterm neonates. Acta Pediatr Scand 1983; 72: 251–254.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Setia, S., Sridhar, M.G., Bhat, V. et al. Growth hormone in Intra-uterine growth retarded newborns. Indian J Pediatr 74, 991–994 (2007). https://doi.org/10.1007/s12098-007-0182-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-007-0182-z